K.H. Shin

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

James D. Cox, N. Azarnia, Roger W. Byhardt et al. · Journal of Clinical Oncology · 1990 · 471 citations

Surgical Oncology, Treatment Verification, Radiation Medicine +19

Misonidazole combined with hyperfractionation in the management of malignant glioma

Dorcas Fulton, Raul C. Urtasun, K.H. Shin et al. · International Journal of Radiation Oncology*Biology*Physics · 1984 · 98 citations

Neuro-oncology, Malignant Glioma, High-grade Gliomas +5

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group

James D. Cox, N. Azarnia, Roger W. Byhardt et al. · International Journal of Radiation Oncology*Biology*Physics · 1991 · 90 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +9

Influence of detector size in photon beam profile measurements

Cláudio H. Sibata, H Mota, A S Bedder et al. · Physics in Medicine and Biology · 1991 · 84 citations

Influence of hip prostheses on high energy photon dose distributions

Cláudio H. Sibata, H Mota, Patrick D. Higgins et al. · International Journal of Radiation Oncology*Biology*Physics · 1990 · 46 citations

Treatment Verification, Radiation Exposure, Surgery +5